The safe and secure management of medications is a fundamental responsibility of healthcare organizations and an essential component of regulatory compliance. Medications are integral to modern medical therapy, supporting the treatment and management of conditions ranging from hypertension and infection to pain, chronic disease, and acute emergencies. While ensuring medication availability is critical to patient care, healthcare organizations have an equally important obligation to protect medications from unauthorized access, tampering, theft, and diversion.
Medication security is not simply an operational concern—it is a regulatory compliance requirement. Failure to establish and maintain effective controls can place patients at risk and expose an organization to findings during regulatory surveys.
The Centers for Medicare & Medicaid Services (CMS) Hospital Conditions of Participation (CoP) establish clear expectations for the security of drugs and biologicals. Under §482.25(b)(2)(i), CMS requires that:
“All drugs and biologicals must be kept in a secure area, and locked when appropriate.”
Although the regulatory language appears straightforward, implementation requires organizations to make deliberate decisions regarding medication storage, access, physical security, authorized personnel, and ongoing monitoring. Organizations must be able to demonstrate not only that policies exist, but that medication security practices are consistently implemented throughout the facility.
Consultant observations across multiple healthcare organizations indicate that medication access and security are often addressed inconsistently. Common vulnerabilities include poorly defined policies, unclear definitions of authorized personnel, inadequate controls in unattended clinical areas, unsecured medication waste, and limited auditing of medication storage practices. These gaps can create significant compliance risk, particularly when an organization cannot demonstrate how it prevents unauthorized access to medications.
CMS does not prescribe a single method for securing every medication or medication storage location. Instead, the CoP establishes a performance expectation: medications must be protected from unauthorized access.
This distinction is important. Compliance cannot be achieved solely by installing locks or purchasing secure storage equipment. Organizations must evaluate whether their overall medication management system effectively prevents unauthorized individuals from obtaining access to drugs and biologicals.
A compliant approach should address several fundamental questions:
Organizations should be prepared to demonstrate that these questions have been considered through formal policies, risk assessments, operational procedures, and ongoing monitoring activities.
While all drugs and biologicals must be protected from unauthorized access, certain medications require heightened security.
Controlled substances classified under Schedules II, III, IV, and V require stringent security controls and must be secured in accordance with applicable federal and state requirements. Organizations should ensure that storage methods provide appropriate protection against theft and diversion.
Automated medication dispensing systems that require unique login credentials, biometric authentication, or other access controls may also provide an appropriate level of security when access is restricted to authorized personnel.
However, organizations should avoid assuming that a particular storage device automatically establishes compliance. Surveyors may evaluate whether the storage method effectively prevents unauthorized access under actual operating conditions. For example, a locked medication cabinet located in an area freely accessible to the public may present a different level of risk than the same cabinet located within a continuously monitored clinical area.
Non-controlled drugs and biologicals may be subject to greater flexibility in storage arrangements; however, they must still be protected from tampering and unauthorized access. Areas where authorized staff are actively providing patient care or preparing procedures may be considered secure when access is appropriately controlled. When those areas become unattended, organizations must ensure that medications remain inaccessible to unauthorized individuals.
This requirement applies to fixed medication storage locations as well as mobile medication carts, including nursing, anesthesia, procedural, and epidural carts. Organizations must establish clear expectations for securing carts when they are unattended or located outside of a secure environment.
One of the most important compliance considerations is determining what constitutes a “secure area.”
From a regulatory perspective, a secure area is not defined solely by whether a door is locked. Rather, the environment must effectively prevent unmonitored access by unauthorized individuals. Organizations should evaluate the physical environment, staffing patterns, patient and visitor access, and the type of medications stored when determining whether an area meets this expectation.
Medication storage locations should not be accessible to patients, visitors, or other individuals who have not been authorized by the organization to access medications.
Areas such as private offices, treatment rooms, ambulatory infusion areas, and other clinical spaces may be considered secure under certain circumstances. However, organizations should not rely solely on the designation of a space. The actual conditions of operation must support the determination that unauthorized access is prevented.
For example, a clinical area may be secure during normal operating hours because authorized staff are continuously present, and access is controlled. That same area may become non-secure after hours when staffing is reduced, and doors remain unlocked.
This operational reality creates an important compliance obligation: organizations must evaluate medication security based on changing conditions rather than assuming that an area remains secure at all times.
Units such as labor and delivery, intensive care, and other continuously staffed patient care areas may generally support a secure environment. Nevertheless, organizations should maintain policies and procedures that define access expectations and establish controls for patients, visitors, contractors, and other non-authorized individuals.
Operating rooms and procedural suites require particular attention because their security status may change throughout the day.
An operating room suite may be considered secure while staff are actively present and providing patient care. However, when procedures have concluded and the area becomes unattended, medication storage must continue to be protected from unauthorized access.
Organizations should establish clear procedures addressing medication security during:
Depending on the environment and organizational risk assessment, appropriate controls may include locking the procedural suite, securing medication carts, removing medications from carts, or relocating carts to a secure storage location.
Survey readiness requires more than having a general expectation that staff will secure medications. Organizations should establish specific procedures defining responsibility for medication security when procedural areas transition from active use to unattended status.
CMS further addresses access to medication storage areas under CoP §482.25(b)(2)(iii), which requires that only authorized personnel have access to locked areas where medications are stored.
A critical organizational responsibility, therefore, is clearly defining who is authorized to access medication storage locations.
Organizations should not assume that “employee” status alone constitutes authorization. Access should be based on an individual’s role, responsibilities, and legitimate operational needs.
Medication storage areas frequently contain supplies or equipment requiring access by individuals who are not directly involved in medication administration. Environmental services personnel may require access for cleaning; engineering staff may require entry for maintenance, and security personnel may require access during emergency situations.
Organizations have flexibility to establish categories of authorized personnel consistent with operational needs and applicable federal, state, and local requirements. Policies may identify categories such as:
Policies do not necessarily need to identify every individual by name. However, they should clearly establish which categories of personnel are authorized, under what circumstances access is permitted, and whether access restrictions differ based on location, time of day, or medication type.
Equally important, organizations must define how unauthorized access is prevented.
If patients, visitors, contractors, or other unauthorized individuals can enter a medication storage area without appropriate oversight, the organization should evaluate whether its existing controls are sufficient. The presence of a written policy alone will not mitigate a compliance concern if actual practice allows unrestricted access.
Patient self-administration presents another area requiring clear regulatory and operational controls.
Many hospitals permit patients to self-administer selected medications, particularly when timely access is clinically important. Examples may include nitroglycerin tablets, inhalers, topical medications, and ophthalmic preparations.
When an organization permits self-administration, patients may be authorized to access medications specifically approved for that purpose. However, this practice should be supported by policies and procedures that address both medication management and security.
Organizations should consider:
A risk-based approach is particularly important. The organization should balance the clinical benefit of immediate medication access with the need to prevent unauthorized access by visitors, other patients, or individuals entering the patient care environment.
Policies should clearly distinguish between authorized patient access to specifically approved medications and unrestricted access to medications stored at the bedside.
Medication security obligations do not end when a medication is removed from active inventory.
Medication waste can represent a significant vulnerability if unused, partially used, expired, or discarded drugs remain accessible to unauthorized individuals. Pharmaceutical waste containers, medication disposal areas, and procedural rooms should be included in organizational medication security assessments.
For example, partially used medication vials placed in an unsecured waste container may remain accessible to individuals who are not authorized to handle medications. This creates potential risks involving diversion, tampering, employee safety, and regulatory noncompliance.
Organizations should establish standardized procedures for the disposal of drugs and biologicals and ensure that processes are consistently implemented across all departments.
Compliance monitoring should evaluate whether:
A compliant disposal process that is inconsistently implemented does not adequately mitigate organizational risk.
Medication security should not be treated as a one-time policy review or an activity conducted only in preparation for a regulatory survey. Maintaining compliance requires ongoing oversight.
Organizations should establish monitoring processes designed to identify vulnerabilities before they result in unauthorized access, diversion, or a survey finding.
Monitoring activities may include:
Leadership should ensure that monitoring activities extend beyond pharmacy-controlled areas. Medication security vulnerabilities frequently occur in decentralized locations, including procedural areas, diagnostic departments, patient care units, anesthesia workspaces, clinics, and other locations where medications are temporarily stored or used.
Evidence of tampering, unexplained inventory discrepancies, unsecured medications, unauthorized access, or suspected diversion should trigger prompt investigation and corrective action.
Corrective actions should address not only the immediate event but also the underlying system failure. This may require policy revision, environmental modifications, access-control changes, staff education, enhanced monitoring, or changes to workflow.
A strong medication security program requires alignment between regulatory requirements, organizational policy, and frontline practice.
Healthcare organizations should periodically conduct a comprehensive assessment of medication security that includes the following elements:
Policy Review
Ensure policies clearly define secure areas, authorized personnel, medication storage requirements, unattended areas, mobile carts, patient self-administration, and medication waste.
Environmental Assessment
Evaluate all locations where medications are stored, prepared, transported, administered, or discarded.
Access Control Evaluation
Determine who can access medication storage areas and whether current controls effectively prevent unauthorized entry.
After-Hours Assessment
Identify areas that may be secure during normal operations but become vulnerable during evenings, weekends, holidays, or periods of reduced staffing.
Staff Education
Ensure personnel understand their responsibilities for securing medications and recognize situations that may create unauthorized access.
Ongoing Monitoring
Implement routine audits and inspections to validate that policies are consistently followed in practice.
Corrective Action and Improvement
Use findings from audits, incidents, and investigations to address system vulnerabilities and strengthen controls.
Medication security is a fundamental regulatory, operational, and patient safety responsibility. CMS Conditions of Participation require healthcare organizations to ensure that drugs and biologicals are maintained in secure areas and protected from unauthorized access. Achieving compliance requires more than locked cabinets or written policies.
Organizations must clearly define secure areas, establish who is authorized to access medications, evaluate changing environmental conditions, address vulnerabilities involving unattended locations and medication waste, and implement ongoing monitoring processes.
The most effective compliance programs take a proactive approach. Rather than waiting for a regulatory survey or diversion event to identify weaknesses, healthcare organizations should routinely assess how medications are accessed, stored, transported, and discarded throughout the organization.
Ultimately, sustained compliance depends on an organization’s ability to translate regulatory expectations into reliable operational practices. By establishing clear controls, continuously monitoring performance, and promptly addressing vulnerabilities, healthcare organizations can reduce regulatory risk while strengthening medication security and protecting patient safety.
Talk with our team about compliance, accreditation, or infection control support.
By submitting, you agree to be contacted by Courtemanche & Associates.
